YZY Med recently participated in the esteemed Thailand Lab International 2024 in mid-September, this event stands as one of Asia’s leading laboratory platforms, attracting key stakeholders from across the globe to showcase innovative products and explore potential collaborations in the fields of laboratory, life sciences, and healthcare technology.
YZY Med supplies cancer, tumor, and cardiovascular-related kits and devices for medium to large hospitals and laboratories, providing critical auxiliary diagnostic support. We presented its cutting-edge clinical-grade qPCR kits, CTC Separator Biopsy A10, and FISH probes, notably compatible with most qPCR instruments and fluorescent microscopes available on the market.
This compatibility allows healthcare providers to integrate our solutions into their existing systems, ensuring efficient and accurate diagnostic processes.
Focused on integrating our advanced solutions into broader healthcare applications, the International team had productive discussions and exchanges with industry partners, exploring the possibility of jointly promoting these products. YZY attached great importance to the Thai market due to its significant growth potential, we visited 2 local medical labs allowing us to understand the overview of the local labs. Meanwhile we conducted market research for the upcoming launch of respiratory testing kits.
YZY will continue to be committed to exploring strategic partnerships, and providing high-quality products and services to benefit patients worldwide with innovative cancer and oncology solutions!
